Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192477PMC
http://dx.doi.org/10.20945/2359-4292-2024-0014DOI Listing

Publication Analysis

Top Keywords

fibrosis steatosis
4
steatosis best
4
best screening
4
screening target?
4
target? comment
4
comment brazilian
4
brazilian evidence-based
4
evidence-based guideline
4
guideline screening
4
screening diagnosis
4

Similar Publications

Background: This study aimed to investigate the gender-specific associations of skeletal muscle mass and fat mass with non-alcoholic fatty liver disease (NAFLD) and NAFLD-related liver fibrosis in two population-based studies.

Methods: Analyses were based on data from the MEGA (n = 238) and the MEIA study (n = 594) conducted between 2018 and 2023 in Augsburg, Germany. Bioelectrical impedance analysis was used to evaluate relative skeletal muscle mass (rSM) and SM index (SMI) as well as relative fat mass (rFM) and FM index (FMI); furthermore, the fat-to-muscle ratio was built.

View Article and Find Full Text PDF

This study explores how human antigen R (HuR) stabilizes fibroblast growth factor 19 (FGF19) mRNA, inhibiting Kupffer cell (KC) activation to reduce inflammation and fibrosis in non-alcoholic fatty liver disease (NAFLD). An animal model of NAFLD was established in mice by administering a high-fat diet (HFD). In vitro study utilized a lipopolysaccharide-induced immortalized mouse KC model.

View Article and Find Full Text PDF

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of conditions from simple steatosis to advanced fibrosis that may represent the cradle for hepatocellular carcinoma. Thus, an accurate assessment of fibrosis is critical for patient management. Noninvasive tools, including serum biomarkers and imaging techniques, have emerged as practical alternatives to liver biopsy, which presents limitations for invasiveness, cost, and sampling variability.

View Article and Find Full Text PDF

Chrysanthemum morifolium Ramat. water extract prevents and treats metabolic-associated fatty liver disease via pan-PPAR activity.

J Ethnopharmacol

September 2025

School of Pharmacy, Anhui University of Chinese Medicine, Hefei, Anhui 230012, China; Anhui Province Key Laboratory of Research & Development of Chinese Medicine, Hefei, Anhui 230012, China. Electronic address:

Ethnopharmacological Relevance: Chrysanthemum (Chrysanthemum morifolium Ramat.) is a widely used plant with both medicinal and dietary applications, boasting a history spanning thousands of years, exhibiting various pharmacological activities such as anti-inflammatory, antipyretic, antibacterial, and antiviral effects. According to the Compendium of Materia Medica, chrysanthemum is renowned for its ability to calm the liver and improve vision.

View Article and Find Full Text PDF

Isoliquiritigenin inhibits the activation of the ANXA2/STAT3 pathway by down-regulating TAGLN2, thereby alleviating alcoholic fatty liver.

Biochem Pharmacol

September 2025

Pharmacy College of Shihezi University/Key Laboratory of Xinjiang Phytomedicine Resource and Utilization, Ministry of Education/Institute for Safflower Industry Research of Shihezi University, Shihezi University, North 4th Road 221, Shihezi, China. Electronic address:

The etiology of alcoholic fatty liver (AFL) is complex, representing the early reversible stage of alcohol-associated liver disease (ALD). Alleviating oxidative stress, reducing inflammation, and preventing the development of liver fibrosis are considered the most effective strategies for treating AFL. Consequently, we selected isoliquiritigenin (ISL), a flavonoid compound recognized for its anti-inflammatory, antioxidant, and anticancer pharmacological properties.

View Article and Find Full Text PDF